Physician

Benjamin K Lambright, M.D.

According to 2025 Medicare claims, Benjamin Lambright, M.D. (NPI: 1417147935) practices ophthalmology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is WEST COAST EYE INSTITUTE PA (NPI: 1437269446; TIN: 593334199) and primary practice location at 34461-9191. Lambright is affiliated with the UF HEALTH ACO JACKSONVILLE, LLC (ACO ID: A5465), participating under the MSSP model.

Lambright's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,394 traditional Medicare patients, billed 71,269 HCPCS/CPT codes, and received $807,912 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,272 prescription claims across 525 beneficiaries totaling $877,597 in drug costs, led by Oxervate (Cenegermin-Bkbj). DME data shows 130 claims. Open Payments data shows 59 records totaling $42,430. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $233,956 to $807,912. Similarly, Part D prescription costs have risen steadily, from $105,680 to $877,597. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	915	2,621	$233,956
2016	1,316	3,527	$342,994
2017	1,534	4,155	$457,650
2018	1,651	4,320	$477,020
2019	1,850	4,749	$494,857
2020	2,030	4,982	$530,438
2021	2,257	5,387	$577,157
2022	2,272	5,900	$621,118
2023	2,389	7,317	$738,739
2024	2,394	71,269	$807,912

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	246	909	$105,680
2016	309	1,027	$129,762
2017	407	1,685	$191,050
2018	424	1,746	$195,349
2019	423	1,687	$474,956
2020	493	1,808	$1,001,157
2021	387	1,542	$400,326
2022	428	1,860	$463,248
2023	471	2,001	$598,572
2024	525	2,272	$877,597

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	52	52	$2,766
2016	79	79	$4,213
2017	97	97	$5,316
2018	151	151	$7,835
2019	114	114	$6,606
2020	131	131	$7,406
2021	141	141	$8,444
2022	184	185	$10,841
2023	177	178	$11,798
2024	130	130	$8,926

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	391	470	$87
92014	Established patient complete exam of visual system	1,574	1,582	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	667	1,215	$62
92134	Imaging of retina	375	573	$27
92133	Imaging of optic nerve	250	257	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxervate	Cenegermin-Bkbj	16	224	$456,140
Restasis	Cyclosporine	163	9,855	$200,002
Cyclosporine	Cyclosporine	84	7,095	$61,089
Rocklatan	Netarsudil Mesylat/Latanoprost	37	1,797	$17,940
Lumigan	Bimatoprost	26	1,646	$14,918

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	34	34	$4,107
V2020	Frames, purchases	N	47	47	$3,196
V2755	U-v lens, per lens	N	49	49	$1,624

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,706	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	15	$40,724	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin K. Lambright, M.D.?

Tedicare shows public-source Medicare data for Benjamin K. Lambright, M.D. (NPI 1417147935), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin K. Lambright, M.D. have ACO affiliation data?

Benjamin K. Lambright, M.D. is shown with ACO affiliation data for UF HEALTH ACO JACKSONVILLE, LLC (MSSP, ACO ID A5465).

What billing organization is linked to Benjamin K. Lambright, M.D.?

Benjamin K. Lambright, M.D. is linked to WEST COAST EYE INSTITUTE PA (billing NPI 1437269446) in the available physician profile data.

Does Benjamin K. Lambright, M.D. have Open Payments data?

Benjamin K. Lambright, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.